Statin use and bleeding risk during vitamin K antagonist treatment for venous thromboembolism: a multicenter retrospective cohort study

Haematologica. 2015 Aug;100(8):e295-8. doi: 10.3324/haematol.2015.127183. Epub 2015 Apr 17.
No abstract available

Keywords: bleeding; cohort study; statins; venous thromboembolism; vitamin K antagonist.

Publication types

  • Letter
  • Multicenter Study

MeSH terms

  • Blood Coagulation / drug effects
  • Fibrinolytic Agents / adverse effects
  • Fibrinolytic Agents / therapeutic use*
  • Hemorrhage / etiology*
  • Hemorrhage / mortality
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Retrospective Studies
  • Venous Thromboembolism / blood
  • Venous Thromboembolism / complications*
  • Venous Thromboembolism / drug therapy*
  • Venous Thromboembolism / mortality
  • Vitamin K / antagonists & inhibitors*

Substances

  • Fibrinolytic Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Vitamin K